Xiao-rong Zhong
Division Of Head & Neck Tumor Multimodality Treatment
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
Journal: Breast cancer research and treatment
Published: November 01, 2023
Differential Diagnosis of DCIS and Fibroadenoma Based on Ultrasound Images: a Difference-Based Self-Supervised Approach.
Journal: Interdisciplinary sciences, computational life sciences
Published: September 05, 2022
The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1-2N1 Breast Cancer.
Journal: Journal of oncology
Published: July 22, 2022
Correction to: The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.
Journal: Annals of surgical oncology
Published: February 27, 2021
ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
Journal: Annals of surgical oncology
Published: December 18, 2020
The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.
Journal: Annals of surgical oncology
Published: August 17, 2020
Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk.
Journal: DNA and cell biology
Published: January 17, 2018
Survival of Patients with Metastatic Recurrent Triple-negative Breast Cancer
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: June 08, 2017
CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity.
Journal: Oncology letters
Published: October 08, 2015
Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.
Journal: Oncology reports
Published: June 25, 2014
Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: June 04, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026